RLMD
Relmada Therapeutics Inc
Price:  
0.61 
USD
Volume:  
151,242.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLMD Intrinsic Value

-1,969.47 %
Upside

What is the intrinsic value of RLMD?

As of 2025-07-09, the Intrinsic Value of Relmada Therapeutics Inc (RLMD) is -11.41 USD. This RLMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.61 USD, the upside of Relmada Therapeutics Inc is -1,969.47%.

Is RLMD undervalued or overvalued?

Based on its market price of 0.61 USD and our intrinsic valuation, Relmada Therapeutics Inc (RLMD) is overvalued by 1,969.47%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

0.61 USD
Stock Price
-11.41 USD
Intrinsic Value
Intrinsic Value Details

RLMD Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -11.41 - -11.41 -11.41 -1,969.47%
P/E (44.21) - (41.93) (43.91) -7297.5%
DDM - Stable (17.38) - (46.88) (32.13) -5366.1%
DDM - Multi (16.02) - (34.21) (21.89) -3687.3%

RLMD Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 20.25
Beta 2.18
Outstanding shares (mil) 33.19
Enterprise Value (mil) 19.10
Market risk premium 4.60%
Cost of Equity 10.78%
Cost of Debt 5.00%
WACC 7.23%